Clinical Efficacy Of Duspatalin In Biliary Tract Pathology


G.Ya. Khismatullina, L.V. Volevach

SBEI HPE "Bashkir State Medical University" of RMPHSD, Ufa
The article presents the results of the study, which evaluated the clinical efficacy of the drug mebeverine (Duspatalin®) in the treatment of diseases of the gallbladder and biliary tract in 68 patients aged 18 to 35 years with a diagnosis of \"chronic noncalculous cholecystitis\". Both groups of 34 patients received conventional therapy. In addition, first group of patients received drug Duspatalin® 200 mg 2 times a day 20 minutes before meals for 30 days. All patients underwent a complete clinical and laboratory and instrumental evaluation. It was noted that the inclusion of Duspatalin in treatment of patients with biliary tract pathology has a pronounced therapeutic effect in the form of an earlier and full relief of pain and dyspeptic syndromes. Administration of Duspatalin promotes correction of motor-tonic disorders of the gall bladder and sphincter system, and normalization of the physicochemical properties of the cystic and liver bile.

About the Autors


Volevach L.V. - Prof., Head of the Department of Outpatient Medicine of Institute of Postgraduate Education SBEI HPE "Bashkir State Medical University" of RMPHSD. E-mail: larisa_volevach@mail.ru;
Khismatullina Gulnaz Yagafarovna – PhD in Medical Sciences, Assistant Professor at the Department of Outpatient Medicine of Institute of Postgraduate Education SBEI HPE "Bashkir State Medical University" of RMPHSD. E-mail: slasg@mail.ru


Similar Articles


Бионика Медиа